Ostabolin-C gel: Completed Phase II enrollment

Zelos completed enrollment in a multi-dose Phase II trial in 48 patients with mild to moderate plaque psoriasis. Patients will receive 1 of 2 doses of twice-daily Ostabolin-C or placebo for 3 months. ...